Cepheid (CPHD -22%) shares plunge after Q2 earnings fell 38%, hurt by higher costs that masked...
Cepheid (CPHD -22%) shares plunge after Q2 earnings fell 38%, hurt by higher costs that masked strong revenue growth, and the company lowered full-year earnings targets. But Baird believes the weakness could be a buying opportunity, citing CPHD's test menu expansion, highly differentiated positioning and strong base growth; the firm rates shares at Outperform.
From other sites
at Zacks.com (Mar 27, 2015)
at 4-traders.com (Mar 24, 2015)
at Investor's Business Daily (Jan 14, 2015)
at Nasdaq.com (Jan 6, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs